Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
Interventional Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Investigator). Phase 1 Inclusion Criteria: - Subjects with Asthma Exclusion Criteria: - Asthma Drug: Zavegepant;Drug: Placebo Allergen induced late asthmatic response (LAR)
Epistemonikos ID: 14a0ddd4ab361320cbde0f90d2b60c3043ab5830
First added on: May 09, 2024